Celator Pharmaceuticals Inc·3

Jan 14, 4:52 PM ET

VENTURES WEST CAPITAL LTD 3

3 · Celator Pharmaceuticals Inc · Filed Jan 14, 2013

Insider Transaction Report

Form 3
Period: 2013-01-14
Holdings
  • Warrants (right to buy)

    (indirect: See footnote)
    Exercise: $5.21Exp: 2019-08-28Common Stock (41,534 underlying)
  • Common Stock

    (indirect: See footnote)
    1,989,541
Footnotes (3)
  • [F1]1,815,280 shares of common stock are held of record by Ventures West 7 Limited Partnership, whose general partner is Ventures West 7 Management Ltd, an entity wholly owned by Ventures West Capital Ltd. and whose officers are similar to the officers of Ventures West Capital Ltd and 174,261 shares of common stock are held of record by Ventures West 7 U.S. Limited Partnership, whose manager is Ventures West 7 Management (International) Inc., an entity controlled by Ventures West Capital Ltd. and whose officers are similar to the officers of Ventures West Capital Ltd. All transactions involving securities held by Ventures West 7 Limited Partnership and Ventures West 7 U.S. Limited Partnership are completed in parallel.
  • [F2]These warrants are fully exercisable.
  • [F3]37,895 warrants are held of record by Ventures West 7 Limited Partnership, whose general partner is Ventures West 7 Management Ltd, an entity wholly owned by Ventures West Capital Ltd. and whose officers are similar to the officers of Ventures West Capital Ltd and 3,639 warrants are held of record by Ventures West 7 U.S. Limited Partnership, whose manager is Ventures West 7 Management (International) Inc., an entity controlled by Ventures West Capital Ltd. and whose officers are similar to the officers of Ventures West Capital Ltd. All transactions involving securities held by Ventures West 7 Limited Partnership and Ventures West 7 U.S. Limited Partnership are completed in parallel.

Documents

1 file
  • 3
    rrd366696.xmlPrimary

    FORM 3